What are INDmoney investors doing with Neuland Laboratories shares?
Based on platform-user behaviour - not analyst opinion or company fundamentals.
Search interest on INDmoney
+9%
Searches for Neuland Laboratories on INDmoney have increased by 9% over the last 30 days.
Among the most traded stocks
313th
Neuland Laboratories was the 313th most traded stock on INDmoney over the last 7 days.
Average holding period of indmoney investors
20 days
INDmoney investors hold Neuland Laboratories shares for an average of 20 days.
Key Events for Neuland Laboratories
Neuland Laboratories Stock Performance
as on November 20, 2026 at 6:01 pm IST
Day's Low
Day's High
₹20,755.00₹21,132.00
0.84%
Downside
0.96%
Upside

52 Week's Low
52 Week's High
₹11,500.00₹24,225.00
45.06%
Downside
15.74%
Upside

Neuland Laboratories share price movements today
- Previous Close
- ₹21,102.00
- Open
- ₹20,933.00
- Volume
- 17.32K
- Upper Circuit
- ₹25,322.00
- Lower Circuit
- ₹16,882.00
- Day's Low - High
- ₹20,755.00 - ₹21,132.00
- 52 Week Low - High
- ₹11,500.00 - ₹24,225.00
Neuland Laboratories Historical Returns
- 1 Month Return
- + 11.21 %
- 3 Month Return
- -10.46 %
- 1 Year Return
- + 26.22 %
- 3 Year Return
- + 291.04 %
- 5 Year Return
- + 1166.51 %
Neuland Laboratories Fundamentals
as on November 20, 2026 at 12:31 pm IST
Market Cap
₹27,073.63 Cr
Return on Equity (ROE)
21.47
PE Ratio (TTM)
59.83
Return on capital employed (ROCE)
26.5
Industry PE ratio
53.91
Beta (LTM)
0.74
P/B Ratio
8.31
Dividend Yield
0.28
PEG Ratio
0.36
Quarterly Earnings Growth YOY
-46.69
EPS (TTM)
282.16
Book Value
1452.37
Neuland Laboratories Stock Valuation
as on November 20, 2026 at 12:31 pm IST
Neuland Laboratories in the last 5 years
Lowest (10.19x)
March 30, 2020
Industry (53.91x)
November 19, 2026
Today (59.83x)
November 19, 2026
Highest (118.16x)
September 16, 2025
Today’s Price to Earnings Ratio: 59.83x
Neuland Laboratories Technical Analysis
Track how Neuland Laboratories technical analysis has moved over time to understand its trends.
Technicals Summary
Bearish
Neutral
Bullish
Moving Averages
Bearish
Neutral
Bullish
Oscillators
Bearish
Neutral
Bullish
Overall
Oscillators
Name | Value | Action |
|---|---|---|
MACD level (12,26) | -3.05 | |
CCI (20) | 46.74 | Neutral |
RSI (14) | 44.37 | Neutral |
Momentum (10) | -1 | Bullish |
ADI (14) | 20.21 | Neutral |
Ultimate Oscillator (7,14,28) | 41.45 | Neutral |
Moving Averages
Name | Value | Action |
|---|---|---|
SMA (20) | 20928.3 | |
EMA (20) | 20925.41 | |
VWMA (20) | 20924.74 | |
SMA (50) | 20927.88 | |
EMA (50) | 20925.1 | |
SMA (200) | 20926.74 | |
EMA (200) | 20948.67 | |
KAMA (200) | 20912.41 | Bullish |
DEMA (200) | 20891.18 | Bullish |
Neuland Laboratories Ltd vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Neuland Laboratories with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
|---|---|---|---|---|---|---|
| BUY | 27,073.63 | 233.3% | 0.57 | 364 | 2,022 | |
| NA | 33.59 | 32.72% | 0.00 | 2 | 127 | |
| BUY | 18,438.36 | 15.71% | 0.69 | 647 | 3,129 | |
| NA | 37.85 | -7.24% | 0.00 | -5 | 10 | |
| BUY | 15,845.40 | 30.46% | 0.51 | 649 | 2,187 |
Market expectation of Neuland Laboratories Stock
Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data
100.00%
Buy
0.00%
Hold
0.00%
Sell
Neuland Laboratories Ltd Quarterly Profit & Loss
Figures in Rupees Crores
Neuland Laboratories Ltd Annual Profit & Loss
Figures in Rupees Crores
Neuland Laboratories Ltd Cash Flow
Figures in Rupees Crores
Mutual Funds Buying / Exiting Neuland Laboratories
Holdings as of 15 Nov 2026 · based on the latest SEBI-mandated portfolio disclosures
Mutual Funds Buying Neuland Laboratories
Sorted by largest increase in holding, month-over-month.
Fund Name | Value of Holding | Increase (MoM) | Holding % |
|---|---|---|---|
HDFC Flexi Cap Fund -Direct Plan - Growth Option | ₹679.77 Cr | ₹97.94 Cr (+16.83%) | 0.58% |
Mutual Funds Exiting Neuland Laboratories
Sorted by largest decrease in holding, month-over-month.
No exiting activity data available right now
Neuland Laboratories Corporate Actions
View detailed summary of the earnings and dividend history of Neuland Laboratories.
Neuland Laboratories Ltd Earnings Results
Neuland Laboratories Ltd’s net profit fell -46.69% since last year same period to ₹51.63Cr in the Q2 2026-2027. On a quarterly growth basis, Neuland Laboratories Ltd has generated -65.04% fall in its net profits since last 3-months.
Read MoreNeuland Laboratories Ltd Dividends May,2026
In the quarter ending March 2026, Neuland Laboratories Ltd has declared dividend of ₹34.00 per share on 12 May 2026 - translating a dividend yield of 0.16%.
Read More about Dividends
Indices Featuring Neuland Laboratories Stock
Check stock indices that include Neuland Laboratories.
Insights on Neuland Laboratories Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise

In the last 3 years, NEULANDLAB stock has moved up by 291.0%
POSITIVE IMPACTFII Holding Up

Foreign Institutions have increased holdings from 21.08% to 21.93% in Sep 2026 quarter
NO EFFECTAgainst Peers

In the last 1 year, Laurus Labs Ltd has given 133.6% return, outperforming this stock by 107.4%
NO EFFECTAgainst Peers

In the last 3 years, Laurus Labs Ltd has given 526.6% return, outperforming this stock by 235.5%
NEGATIVE IMPACTMF Holding Down

Mutual Funds have decreased holdings from 12.66% to 12.45% in Sep 2026 quarter
NEGATIVE IMPACTPromoter Holding Down

Promoters have decreased holdings from 32.62% to 32.26% in Sep 2026 quarter
NEGATIVE IMPACTRevenue Fall

Revenue is down for the last 3 quarters, 788.71 Cr → 457.15 Cr (in ₹), with an average decrease of 23.6% per quarter
NEGATIVE IMPACTRetail Holding Down

Retail Investor have decreased holdings from 29.79% to 29.55% in Sep 2026 quarter
NEGATIVE IMPACTProfit Down

Netprofit is down for the last 3 quarters, 212.67 Cr → 51.63 Cr (in ₹), with an average decrease of 47.8% per quarter
About Neuland Laboratories Ltd
Revenue: ₹449.66Cr as on September 2026 (Q2 FY27)
Net Profit: ₹51.63Cr as on September 2026 (Q2 FY27)
Listing date: 17 May, 1995
Chairperson Name: D Saharsh Rao
| Organisation | Neuland Laboratories Ltd |
| Headquarters | Hyderabad |
| Industry | Pharmaceuticals |
| CEO | D Saharsh Rao |
| E-voting on shares | Click here to vote |
FAQs
What is Neuland Laboratories share price today?
Neuland Laboratories share price today stands at ₹20931 as on . Neuland Laboratories share today touched a day high of ₹21132 and a low of ₹20755.
What is the 52 week high and 52 week low range for Neuland Laboratories share?
Neuland Laboratories touched a 52 week high of ₹24225 and a 52 week low of ₹11500. Neuland Laboratories share price today i.e. is trending at ₹20931, which is -13.60% down from its 52 week high and 82.01% up from its 52 week low.
What is Neuland Laboratories's market capitalisation today?
Neuland Laboratories market capitalisation is ₹27,073.63 Cr as on .
How to buy Neuland Laboratories shares?
To buy Neuland Laboratories shares, you need to follow these steps:
- Open a Demat account and Trading account on INDmoney
- Fund your Trading account
- Search for NEULANDLAB or Neuland Laboratories Ltd on the INDmoney app to check live prices of the stock
- Click on Buy or SIP to place an order to invest in Neuland Laboratories shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.
What is Neuland Laboratories trading volume today?
Neuland Laboratories trading volume is 17.32K as on . This means that 17.32K shares of Neuland Laboratories were bought and sold on the stock market during today's trading session.